Exagen inc. reports unaudited earnings results for the third quarter and nine months ended september 30, 2019; provides earnings guidance for the full year of 2019

Exagen inc. reported unaudited earnings results for the third quarter and nine months ended september 30, 2019. for the quarter, the company reported revenue of $10,439,000 compared to $8,223,000 a year ago. loss from operations was $2,157,000 compared to $1,133,000 a year ago. net loss attributable to common stockholders was $17,080,000 compared to $4,524,000 a year ago. basic and diluted net loss per share was $11.29 compared to $71.80 a year ago.for the nine months, the company reported revenue of $30,173,000 compared to $22,799,000 a year ago. loss from operations was $6,441,000 compared to $4,729,000 a year ago. net loss attributable to common stockholders was $26,871,000 compared to $14,309,000 a year ago. basic and diluted net loss per share was $48.70 compared to $227.11 a year ago.the company provided earnings guidance for the full year of 2019. for the full year 2019, the company expects revenue to be in the range of $40 million to $41 million.
XGN Ratings Summary
XGN Quant Ranking